-+ 0.00%
-+ 0.00%
-+ 0.00%

Recursion Pharmaceuticals Q4 Earnings Report: What Investors Need to Know

Benzinga·02/25/2026 11:34:23
Listen to the news

Recursion Pharmaceuticals (NASDAQ:RXRX) reported its Q4 earnings results on Wednesday, February 25, 2026 at 06:30 AM.

Here's what investors need to know about the announcement.

Earnings

Recursion Pharmaceuticals beat estimated earnings by 30.0%, reporting an EPS of $-0.21 versus an estimate of $-0.3.

Revenue was up $30.99 million from the same period last year.

Overview of Past Earnings

During the previous quarter, the company beat on EPS by $0.02, leading to a 6.85% drop share price change the next day.

Here's a look at Recursion Pharmaceuticals's past performance:

Quarter Q3 2025 Q2 2025 Q1 2025 Q4 2024
EPS Estimate -0.38 -0.35 -0.52 -0.42
EPS Actual -0.36 -0.41 -0.50 -0.53
Revenue Estimate 18.60M 14.98M 18.08M 19.04M
Revenue Actual 5.17M 19.22M 14.74M 4.55M

To track all earnings releases for Recursion Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.